News

Olorofim Phase IIb trial shows efficacy in invasive fungal disease for patients with limited treatment options
Researchers from KU Leuven, the University of California Davis Medical Center, the University of Cologne, and over 20 ...
Fungal infections are getting harder to treat
Fungal infections are getting harder to treat as they grow more resistant to available drugs, according to research published ...
Medscape2d
Novel Antifungal Offers Hope in Resistant Fungal Infections
Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...
Fierce Biotech3d
Basilea secures $39M from BARDA as part of long-term antifungal funding plan
Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...
The Manila Times3d
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Taiwan News3d
Vietnam Invasive Fungal Infection Market Forecast 2024–2032 Addressing Rising Incidence with Advanced Antifungal Therapies and Diagnostics
Vietnam Invasive Fungal Infection Market Key Takeaways: The Vietnam Invasive Fungal Infection (IFI) market is experiencing significant growth propelled by factors such as an increasing incidence of ...